Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Long-term treatment of relapsing-remitting multiple sclerosis with interferon β: how strongly should we encourage patients to adhere to the 'old' therapies?
Employment as a health promotion intervention for persons with multiple sclerosis.
Fingolimod in the treatment of relapsing-remitting multiple sclerosis: long-term experience and an update on the clinical evidence.
Dimethyl fumarate: a review of its use in patients with relapsing-remitting multiple sclerosis.
Core outcome measures for exercise studies in people with multiple sclerosis: recommendations from a multidisciplinary consensus meeting.
Oropharyngeal dysphagia in patients with multiple sclerosis: do the disease classification scales reflect dysphagia severity?
The ICF as a framework to collect and interpret data on the extent and variety of disability in neurological conditions.
Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells.
Preferred features of oral treatments and predictors of non-adherence: two web-based choice experiments in multiple sclerosis patients.
A new therapeutic target for the treatment of multiple sclerosis.
Myelin-derived lipids modulate macrophage activity by liver x receptor activation.
Assessing spinal cord function in multiple sclerosis with functional neuroimaging: insights and limitations.
Central Veins in Brain Lesions Visualized With High-Field Magnetic Resonance Imaging: A Pathologically Specific Diagnostic Biomarker for Inflammatory Demyelination in the Brain.
The primary vascular dysregulation syndrome: implications for eye diseases.
Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome.
Optic Nerve and its Arterial-Venous Vascularization: An Ultrasonologic Study in Multiple Sclerosis Patients and Healthy Controls.
Neurodegeneration in multiple sclerosis is a process separate from inflammation: Yes.
Risk genes associated with pediatric-onset MS but not with monophasic acquired CNS demyelination.
Impact of simulated microgravity on oligodendrocyte development: implications for central nervous system repair.
Cerebral lesions of multiple sclerosis: is gadolinium always irreplaceable in assessing lesion activity?
Multiple sclerosis registries in Europe - results of a systematic survey.
Long-term benefits of induction therapy in NMO: a case report.
Efficacy and Side Effects of Natalizumab Therapy in Patients with Multiple Sclerosis.
Incomplete Septal Cirrhosis After High -Dose Methylprednisolone Therapy And Regression Of Liver Injury.
Tumor necrosis factor beta NcoI polymorphism is associated with inflammatory and metabolic markers in multiple sclerosis patients.

Pages